Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Gynaecological Oncology|January 1, 1991
Alpha 2b interferon (IFN) by intraperitoneal administration via temporary catheter in ovarian cancer. Preliminary dataR V Iaffaioli, G Frasci, G Facchini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Carboplatin and alpha-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot studyG Frasci, A Tortoriello, G Facchini, et al.
Gynecologic Oncology|July 1, 1993
Intraperitoneal (ip) cisplatin-mitoxantrone-interferon-alpha 2b in ovarian cancer patients with minimal residual diseaseG Frasci, A Tortoriello, G Facchini, et al.
Cancer|March 15, 1996
A risk model for ovarian carcinoma patients using CA 125: time to normalization renders second-look laparotomy redundantG Frasci, S Conforti, F Zullo, et al.
International Journal of Oncology|May 14, 2011
Preoperative chemoimmunotherapy with Carboplatin, epidoxorubicin, 5-Fluorouracil and alpha-2b interferon in locally advanced inoperable gastric-cancerR Iaffaioli, F Caponigro, A Tortoriello, et al.
Tumori|February 28, 1990
Partial response of metastatic hepatocellular carcinoma after treatment with thymostimulinG Palmieri, C Gridelli, R Pepe, et al.
Oncology|May 1, 1996
Significance of methotrexate serum level achieved in patients with gastrointestinal malignancies treated with sequential methotrexate, L-folinic acid and 5-fluorouracilP Comella, G Palmieri, G Beneduce, et al.
European Journal of Nuclear Medicine|January 1, 1991
Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinomaL Camera, S Del Vecchio, A Petrillo, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localizationS Del Vecchio, L Camera, A Petrillo, et al.
The International Journal of Biological Markers|April 1, 1990
CA 15-3 in human breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA)F Caponigro, R V Iaffaioli, C Pagliarulo, et al.
Pageof 6